论文部分内容阅读
目的:探究支气管哮喘应用孟鲁司特联合雾化吸入治疗的临床效果。方法 :选取2012年1月至2013年3月在本院呼吸科治疗的支气管哮喘患者46例,按照随机分组原则将哮喘患者分为对照组和治疗组分别23例,两组患者采取不同的治疗方案进行疗效对比。结果:治疗组支气管哮喘患者的临床治疗总有效率明显高于对照组,差异具有统计学意义(P<0.05),同时治疗组患者的住院时长和两年复发率明显低于对照组,差异具有统计学意义(P<0.05)。结论:在支气管哮喘的临床治疗中应用孟鲁司特联合雾化吸入治疗能够显著改善患者的临床治疗效果,同时降低其住院时长,减少治疗后病症复发率。
Objective: To investigate the clinical effect of montelukast combined with inhalation therapy on bronchial asthma. Methods: Forty-six patients with bronchial asthma undergoing respiratory department in our hospital from January 2012 to March 2013 were randomly divided into control group and treatment group according to the principle of randomization. Twenty-three patients were treated with different treatment Program efficacy comparison. Results: The total effective rate of clinical treatment in patients with bronchial asthma in the treatment group was significantly higher than that in the control group (P <0.05), while the length of hospitalization and the recurrence rate in two years in the treatment group were significantly lower than those in the control group Statistical significance (P <0.05). Conclusion: The application of montelukast combined with inhalation of nebulization in the clinical treatment of bronchial asthma can significantly improve the clinical efficacy of patients, meanwhile, reduce the duration of hospitalization and reduce the recurrence rate after treatment.